Krystal Biotech EBITDA 2017-2024 | KRYS

Krystal Biotech EBITDA for the quarter ending September 30, 2024 was $0.024B, a 197.3% decline year-over-year.

  • Krystal Biotech 2023 EBITDA was -0.106B, a 24.9% decline from 2022.
  • Krystal Biotech 2022 EBITDA was -0.141B, a 115.46% increase from 2021.
  • Krystal Biotech 2021 EBITDA was -0.066B, a 110.31% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Krystal Biotech EBITDA 2017-2024 | KRYS

  • Krystal Biotech 2023 EBITDA was -0.106B, a 24.9% decline from 2022.
  • Krystal Biotech 2022 EBITDA was -0.141B, a 115.46% increase from 2021.
  • Krystal Biotech 2021 EBITDA was -0.066B, a 110.31% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.